Results 1 to 10 of about 297,519 (217)
Determinants of felt demand for dengue vaccines in the North Caribbean region of Colombia
Annals of Clinical Microbiology and Antimicrobials, 2017 Background The increasing burden associated with dengue in Latin America makes it essential to understand the community’s interest in acquiring vaccines, as an input to plan its introduction in endemic regions. The objective of this study is to learn the
Yalil T. Bracho-Churio +5 more
doaj +1 more source
Dengue Vaccines: Current Status and Future Perspectives
APIK Journal of Internal MedicineDengue fever (DF), caused by the dengue virus (DENV), is a major public health problem worldwide, with approximately 390 million reported annual infections.
Vasantha Kamath, A. B. Aishwarya
doaj +1 more source
Dengue Vaccine: The Current Status [PDF]
Medical Journal Armed Forces India, 2008 Dengue fever is a re-emerging public health problem with two-fifths of the world population being at risk of infection. Since there are no antiviral drugs available against the dengue virus, and vector control programmes have been largely unsuccessful in preventing outbreaks, vaccination seems to be the most viable option for preventing infection.
M S, Mustafa, V K, Agrawal
openaire +2 more sources
Opportunities and challenges of mRNA technologies in development of dengue virus vaccine
Frontiers in ImmunologyDengue virus (DENV) is a mosquito-borne virus with a significant human health concern. With 390 million infections annually and 96 million showing clinical symptoms, severe dengue can lead to life-threatening conditions like dengue hemorrhagic fever (DHF)
Xiaoyang Liu
doaj +1 more source
Dengue virus infection in a course of typhoid fever
Journal of Education, Health and Sport, 2018 Dengue is a mosquito-borne viral infection caused by dengue virus (DENV) belonging to a group of Flaviviridae. Disease is widely spread in tropical and subtropical regions of Southeast Asia, Africa and the Americas.
Aleksander Ryczkowski +4 more
doaj +3 more sources
Dengue vaccine acceptance and willingness to pay
Human Vaccines & Immunotherapeutics, 2017 The introduction of new vaccines is accompanied by a variety of challenges. Among these, very important ones concern the questions whether the public is willing to accept and willing to purchase the vaccine.
Harapan Harapan +3 more
doaj +1 more source
Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype. [PDF]
PLoS Neglected Tropical Diseases, 2018 Dengue virus (DENV) is the causative agent of dengue fever and dengue hemorrhagic shock syndrome. Dengue vaccine development is challenging because of the need to induce protection against four antigenically distinct DENV serotypes.
Stefan W Metz +10 more
doaj +1 more source
IMC Journal of Medical ScienceBackground and Objectives: Dengue fever, caused by four serotypes of the dengue virus (DENV), is a global health threat, affecting millions of people annually, with a significant burden in Asian countries. Bangladesh, where dengue was first documented in
M. S. Zaman, Amal K. Mitra
doaj +1 more source
Prevention and Control Strategies to Counter Dengue Virus Infection
Frontiers in Cellular and Infection Microbiology, 2017 Dengue is currently the highest and rapidly spreading vector-borne viral disease, which can lead to mortality in its severe form. The globally endemic dengue poses as a public health and economic challenge that has been attempted to suppress though ...
Irfan A. Rather +6 more
doaj +1 more source
Risk of Dengue in Travelers: Implications for Dengue Vaccination [PDF]
Current Infectious Disease Reports, 2018 Dengue is found in tropics and subtropics that are considered to be popular travel destinations. We set out to review the burden of dengue on international travelers.GeoSentinel, a global network of travel medicine providers, has seen an increasing trend of dengue in returning travelers over the past decades.
openaire +2 more sources